欧视通在白内障人工晶状体屈光度计算中的应用

注册号:

Registration number:

ChiCTR1800014806 

最近更新日期:

Date of Last Refreshed on:

2018-02-07 11:34:15 

注册时间:

Date of Registration:

2018-02-07 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

欧视通在白内障人工晶状体屈光度计算中的应用

Public title:

Application of Ophtha Top in intraouclar lens (IOL) power calculation incataract patients

注册题目简写:

English Acronym:

研究课题的正式科学名称:

欧视通计算白内障人工晶状体屈光度准确性研究

Scientific title:

Accuracy of Ophtha Top in intraouclar lens (IOL) power calculation incataract patients

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

于莎莎 

研究负责人:

汤欣 

Applicant:

YU SHASHA 

Study leader:

TANG XIN 

申请注册联系人电话:

Applicant telephone:

+86 13672031356

研究负责人电话:

Study leader's
telephone:

+86 022-27313336

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

yushashaty@163.com

研究负责人电子邮件:

Study leader's E-mail:

professortangxin@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

天津市和平区甘肃路4号 天津市眼科医院

研究负责人通讯地址:

天津市和平区甘肃路4号 天津市眼科医院

Applicant address:

4 Gansu Road, Heping District, Tianjin, China

Study leader's address:

4 Gansu Road, Heping District, Tianjin, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

天津市眼科医院

Applicant's institution:

Tianjin Eye Hospital

研究负责人所在单位:

天津市眼科医院

Affiliation of the Leader:

Tianjin Eye Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

TJYYLL-2017-9

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

天津市眼科医院伦理委员会

Name of the ethic committee:

Research Review Board of the Tianjin Eye Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2017-11-01 00:00:00

伦理委员会联系人:

湛保民

Contact Name of the ethic committee:

ZHAN BAOMIN

伦理委员会联系地址:

天津市和平区甘肃路4号 天津市眼科医院

Contact Address of the ethic committee:

4 Gansu Road, Heping District, Tianjin, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

天津市眼科医院

Primary sponsor:

Tianjin Eye Hospital

研究实施负责(组长)单位地址:

天津市和平区甘肃路4号

Primary sponsor's address:

4 Gansu Road, Heping District, Tianjin, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

经费或物资来源:

Source(s) of funding:

not applicable

研究疾病:

人工晶状体屈光度计算  

Target disease:

IOL power calculation

研究疾病代码:

Target disease code:

研究类型:

诊断试验

Study type:

Diagnostic test

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

诊断试验诊断准确性 

Study design:

Diagnostic test for accuracy 

研究目的:

研究欧视通计算人工晶状体屈光度的准确性,以及其与IOLMaster的一致性  

Objectives of Study:

To value the accuracy of Ophtha Top in IOL power calculation in cataract patient,and the consistency with IOLMater

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

1)眼表疾病患者,接受过角膜屈光手术或者角膜外伤患者;虹膜炎;外伤性白内障等。
2) 复杂白内障手术者等

Exclusion criteria:

1) ocular deseases,corneal refractive surgery, corneal trauma,uveitis, traumatic cataract;
2) complicated cataract surgery.

研究实施时间:

Study execute time:

From 2013-10-10 00:00:00 To 2016-05-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2013-10-01 00:00:00 To 2016-05-31 00:00:00

诊断试验:

Diagnostic Tests:

金标准或参考标准(即可准确诊断某疾病的单项方法或多项联合方法,在本研究中用于诊断是否有该病的临床参考标准):

IOLMaster

Gold Standard or Reference Standard (The clinical reference standards required to establish the presence or absence of the target condition in the tested population in present study):

IOLMaster

指标试验(即本研究的待评估诊断试验,无论为方法、生物标志物或设备,均请列出名称):

欧视通

Index test:

Ophtha Top

目标人群(可以是某种疾病患者或正常人群,详细描述其疾病特征,注意应纳入符合分布特点的全序列病例,具有良好的代表性)

常规白内障超声乳化联合人工晶状体植入术术后,1周复诊患者眼部检查未见异常,恢复良好者且能够配合完成后期检查以及随诊的患者

例数:

Sample size:

105

Target condition (The target condition is a particular disease or disease stage that the index test will be intended to identify. Please specify the characteristics in detail; the population should has a complete spectrum and good representative):

Patients received routine phacomulcification and IOL implantation surgery,1week return visit reported no abnormal symptoms and could complete all the following checks.

容易混淆的疾病人群(即与目标疾病不易区分的一种或多种不同疾病,应避免采用正常人群对照的病例-对照设计):

例数:

Sample size:

0

Population with condition difficult to distinguish from the target condition, the normal population in a case-control study design should be avoid:

研究实施地点:

Countries of recruitment and research settings:

测量指标:

Outcomes:

指标中文名:

屈光度

指标类型:

主要指标

Outcome:

IOL power calculation

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

征募研究对象情况:

Recruiting status:

结束

/Completed

年龄范围:

Participant age:

最小 Min age years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

NA

Randomization Procedure (please state who generates the random number sequence and by what method):

NA

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

中国临床试验注册中心

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

www.chictr.org.cn

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

数据采集:病例登记表格 数据管理: excel,spss 等统计软件

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Data collecting: case record forms Data managing: excel,spss

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2018-02-07 11:34:16